Financials
- Market Capitalization 19.46 M
- Employee 14
- Founded 2008
- CEO Steven C. Quay
- Website www.atossatherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG002NCD8C8
- Industry Biotechnologie
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 4621 | KALA KALA BIO, Inc. - Common Stock | 1.05 USD | -3.67% | -30.00% | -60.82% | -81.90% | 19.52 M USD | ||
| 4625 | JSPR Jasper Therapeutics, Inc. - Class A Common Stock | 0.68 USD | +11.48% | +47.83% | +51.11% | -80.57% | 19.04 M USD | ||
| 4631 | LGVN Longeveron Inc. - Class A Common stock | 0.63 USD | 0.00% | -3.08% | -23.17% | +10.27% | 19.62 M USD | ||
| 4636 | NEUP Neuphoria Therapeutics Inc. - Common Stock | 3.61 USD | +3.44% | -1.90% | -20.66% | -52.81% | 19.51 M USD |